Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions
NCT01321515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2018-01-23
Summary
The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.
Conditions
- Herpes
Interventions
- DRUG
-
famciclovir
500 mg tablet
Sponsors & Collaborators
-
Roxane Laboratories
lead INDUSTRY
Principal Investigators
-
Benno G Roesch, M.D. · Advanced Biomedical Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2007-07-31
- Completion
- 2007-07-31
Countries
- United States
Study Locations
More Related Trials
-
RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir
NCT00219310 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
NCT01154543 ·Status: COMPLETED
-
Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
NCT00649974 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis
NCT00248144 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding
NCT00129818 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes
NCT00306787 ·Status: COMPLETED ·Phase: PHASE3
-
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
NCT00098059 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes
NCT00171990 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food
NCT02852876 ·Status: COMPLETED ·Phase: PHASE1
-
Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg
NCT00650494 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
NCT02412917 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers
NCT02226978 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
NCT00527618 ·Status: COMPLETED ·Phase: PHASE4
-
A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years
NCT04762511 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers
NCT02322957 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons
NCT00079911 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
NCT00448227 ·Status: COMPLETED ·Phase: PHASE2
-
The Bioequivalence Study of Acyclovir 800 mg Tablet in Healthy Thai Volunteers Under Fasting Conditions
NCT06228430 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
NCT00900783 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected Patients
NCT00002404 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
NCT01143181 ·Status: COMPLETED ·Phase: PHASE3
-
Valaciclovir to Prevent Transmission of Herpes Simplex Virus
NCT00001649 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir
NCT01689285 ·Status: COMPLETED ·Phase: PHASE1
-
Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection
NCT00098046 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
NCT01281007 ·Status: COMPLETED ·Phase: PHASE3